Status:
RECRUITING
Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
Lead Sponsor:
T1D Exchange, United States
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
2-95 years
Phase:
NA
Brief Summary
The overall goal of the study is to create a standardized, stakeholder-informed system within EMRs, that will enable an equitable and regular prescription and documentation of advanced diabetes techno...
Detailed Description
For the proposed study we intend to implement an automatically delivered center decision support system provided at the time and location of the decision making along with actionable recommendations a...
Eligibility Criteria
Inclusion
- Age ≥ 2 years with an EMR diagnosis of T1D for at least 6 months at baseline and receiving care at one of six intervention centers or a matched control at another T1DX-QI center.
- non-Hispanic Black and Hispanic individuals
Exclusion
- PwT1D with evidence of use of AID at baseline
Key Trial Info
Start Date :
August 13 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2027
Estimated Enrollment :
1178 Patients enrolled
Trial Details
Trial ID
NCT06931275
Start Date
August 13 2024
End Date
July 30 2027
Last Update
April 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
T1D Exchange
Boston, Massachusetts, United States, 02110
2
T1D Exchange
Boston, Massachusetts, United States, 02111